Gemcitabine-induced thrombotic microangiopathy;Microangiopathie thrombotique due à la gemcitabine

Presse Medicale

Volumn 31, Issue 16, 2002, Pages 740-742

  Teixeira, L ^a   Debourdeau, Philippe ^a   Zammit, C ^a   Estival, J L ^a   Pavic, M ^a   Colle, B ^a  

^a Service de Medecine Interne   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; INCIDENCE; MALE; METASTASIS; PROGNOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; UROGENITAL TRACT TUMOR;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BONE NEOPLASMS; DEOXYCYTIDINE; HUMANS; MALE; NEOPLASM METASTASIS; THROMBOSIS; UROLOGIC NEOPLASMS; VASCULAR DISEASES;

EID: 0037181744     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Haemolytic-uraemic syndrome: Basic science
2. Gemcitabine safety overview
3. Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: A phase II study
4. Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: A phase II study
5. Thrombotic microanglopathy with renal failure in two patients undergoing gemcitabine chemotherapy
6. Thrombotic micraangiopathy as a complication of long-terme therapy with gemcitabine
7. A phase II study of gemcitabine in patient with malignant pleural mesothelioma
8. Haemolytic-ureamic syndrome in practice
9. Microangiopathic haemolytic anemia in metastatic carcinoma: Report of height cases
10. Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents
11. Cancer associated hemolytic-uremic syndrome: Analysis of 85 cases from a national registry
12. Thrombotic microangiopathy manifesting asthrombotic thrombocytopnic purpura/Hemolytic uremic syndrome in the cancer patient
13. A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy